REPLIGEN CORP Cost of Goods Sold (Deprecated 2018-01-31)
REPLIGEN CORP (RGEN) reported Cost of Goods Sold (Deprecated 2018-01-31) of $19.67 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-08
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $19.67M, a 40.59% increase year-over-year.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $19.14M, a 57.34% increase year-over-year.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $19.99M, a 77.79% increase year-over-year.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $13.94M, a 10.23% increase year-over-year.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $67.05M, a 42.31% increase from fiscal 2016.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $47.12M, a 33.66% increase from fiscal 2015.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $35.25M, a 25.80% increase from fiscal 2014.
- REPLIGEN CORP cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $28.02M, a 24.65% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $19.67M 10-Q · filed 2018-05-08 | $38.80M derived: sum of 2 quarters · filed 2018-05-08 | $58.79M derived: sum of 3 quarters · filed 2018-05-08 | $72.73M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-12-31 | $19.14M 10-K · filed 2018-02-22 | $39.12M derived: sum of 2 quarters · filed 2018-02-22 | $53.06M derived: sum of 3 quarters · filed 2018-02-22 | $67.05M 10-K · filed 2018-02-22 | ||||
| 2017-09-30 | $19.99M 10-K · filed 2018-02-22 | $33.92M derived: sum of 2 quarters · filed 2018-02-22 | $47.91M 10-Q · filed 2017-11-09 | $60.08M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-06-30 | $13.94M 10-K · filed 2018-02-22 | $27.93M 10-Q · filed 2017-08-03 | $40.09M derived: sum of 3 quarters · filed 2018-05-08 | $51.33M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-03-31 | $13.99M 10-Q · filed 2018-05-08 | $26.15M derived: sum of 2 quarters · filed 2018-05-08 | $37.39M derived: sum of 3 quarters · filed 2018-05-08 | $50.04M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $12.16M 10-K · filed 2018-02-22 | $23.40M derived: sum of 2 quarters · filed 2018-02-22 | $36.05M derived: sum of 3 quarters · filed 2018-02-22 | $47.12M 10-K · filed 2018-02-22 | ||||
| 2016-09-30 | $11.24M 10-K · filed 2018-02-22 | $23.89M derived: sum of 2 quarters · filed 2018-02-22 | $34.95M 10-Q · filed 2017-11-09 | $45.10M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $12.64M 10-Q · filed 2017-08-03 | $23.71M 10-Q · filed 2017-08-03 | $33.86M derived: sum of 3 quarters · filed 2018-02-22 | $42.30M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $11.07M 10-K · filed 2018-02-22 | $21.22M derived: sum of 2 quarters · filed 2018-02-22 | $29.66M derived: sum of 3 quarters · filed 2018-02-22 | $38.25M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $10.15M 10-K · filed 2017-02-23 | $18.59M derived: sum of 2 quarters · filed 2017-02-23 | $27.18M derived: sum of 3 quarters · filed 2017-02-23 | $35.25M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $8.44M 10-K · filed 2017-02-23 | $17.03M derived: sum of 2 quarters · filed 2017-02-23 | $25.10M 10-Q · filed 2016-11-03 | $33.19M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $8.59M 10-K · filed 2017-02-23 | $8.59M 10-Q · filed 2015-08-06 | $16.66M 10-Q · filed 2016-08-04 | $16.66M 10-Q · filed 2015-08-06 | $24.74M derived: sum of 3 quarters · filed 2017-02-23 | $31.67M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $8.07M 10-K · filed 2017-02-23 | $8.07M 10-Q · filed 2015-05-08 | $16.16M derived: sum of 2 quarters · filed 2017-02-23 | $23.09M derived: sum of 3 quarters · filed 2017-02-23 | $29.76M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $8.08M 10-K · filed 2016-02-25 | $15.02M derived: sum of 2 quarters · filed 2016-02-25 | $21.69M derived: sum of 3 quarters · filed 2016-02-25 | $28.02M 10-K · filed 2017-02-23 | $28.02M 10-K · filed 2015-03-17 | |||
| 2014-09-30 | $6.93M 10-K · filed 2016-02-25 | $6.93M 10-Q · filed 2014-11-07 | $13.60M derived: sum of 2 quarters · filed 2016-02-25 | $19.94M 10-Q · filed 2015-11-05 | $19.94M 10-Q · filed 2014-11-07 | $24.56M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $6.67M 10-K · filed 2016-02-25 | $6.67M 10-Q · filed 2014-08-11 | $13.01M 10-Q · filed 2015-08-06 | $17.63M derived: sum of 3 quarters · filed 2016-02-25 | $23.29M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $6.33M 10-K · filed 2016-02-25 | $6.34M 10-Q · filed 2014-05-09 | $10.96M derived: sum of 2 quarters · filed 2016-02-25 | $16.62M derived: sum of 3 quarters · filed 2016-02-25 | $21.92M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $4.63M 10-K · filed 2015-03-17 | $10.29M derived: sum of 2 quarters · filed 2015-03-17 | $15.58M derived: sum of 3 quarters · filed 2015-03-17 | $22.48M 10-K · filed 2016-02-25 | $22.48M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $5.66M 10-K · filed 2015-03-17 | $5.66M 10-Q · filed 2013-11-08 | $10.96M derived: sum of 2 quarters · filed 2015-03-17 | $17.85M 10-Q · filed 2014-11-07 | $23.77M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2013-06-30 | $5.30M 10-K · filed 2015-03-17 | $5.30M 10-Q · filed 2013-08-07 | $12.19M 10-Q · filed 2014-08-11 | $18.11M derived: sum of 3 quarters · filed 2015-03-17 | $24.53M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2013-03-31 | $6.90M 10-K · filed 2015-03-17 | $6.90M 10-Q · filed 2013-05-07 | $12.82M derived: sum of 2 quarters · filed 2015-03-17 | $19.24M derived: sum of 3 quarters · filed 2015-03-17 | $26.58M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2012-12-31 | $5.92M 10-K · filed 2014-03-14 | $12.34M derived: sum of 2 quarters · filed 2014-03-14 | $19.68M derived: sum of 3 quarters · filed 2014-03-14 | $24.96M 10-K · filed 2015-03-17 | ||||
| 2012-09-30 | $6.42M 10-K · filed 2014-03-14 | $6.42M 10-Q · filed 2012-11-08 | $13.76M derived: sum of 2 quarters · filed 2014-03-14 | $19.04M 10-Q · filed 2013-11-08 | $20.55M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $7.34M 10-K · filed 2014-03-14 | $7.35M 10-Q · filed 2012-08-09 | $12.62M 10-Q · filed 2013-08-07 | $14.13M derived: sum of 3 quarters · filed 2014-03-14 | $16.22M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $5.27M 10-K · filed 2014-03-14 | $5.03M 10-Q · filed 2012-05-10 | $6.78M derived: sum of 2 quarters · filed 2014-03-14 | $8.88M derived: sum of 3 quarters · filed 2014-03-14 | $10.43M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $1.51M 10-K · filed 2013-03-15 | $3.60M derived: sum of 2 quarters · filed 2013-03-15 | $5.16M 10-K · filed 2014-03-14 | $6.55M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2011-09-30 | $2.09M 10-K · filed 2013-03-15 | $2.09M 10-Q · filed 2011-11-09 | $3.65M 10-Q · filed 2011-11-09 | $5.04M 10-Q · filed 2012-11-08 | $6.49M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-06-30 | $1.55M 10-K · filed 2013-03-15 | $1.55M 10-Q · filed 2011-08-05 | $2.95M 10-Q · filed 2012-08-09 | $4.40M derived: sum of 3 quarters · filed 2014-03-14 | $5.87M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-03-31 | $1.39M 10-K · filed 2013-03-15 | $1.39M 10-Q · filed 2012-05-10 | $2.84M derived: sum of 2 quarters · filed 2014-03-14 | $4.31M derived: sum of 3 quarters · filed 2014-03-14 | $5.58M 10-K · filed 2013-03-15 | |||
| 2010-12-31 | $1.45M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $2.92M derived: sum of 2 quarters · filed 2014-03-14 | $4.19M 10-K · filed 2014-03-14 | |||||
| 2010-09-30 | $1.47M 10-Q · filed 2011-11-09 | $2.74M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $1.27M 10-Q · filed 2011-08-05 | |||||||
| 2010-03-31 | $4.16M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |